ZA201701761B
(en )
2019-09-25
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions
IL262126A
(en )
2018-11-29
Macrocycle inhibitors of pd-1/pd-l1 and cd80/pd-l1 interactions
HUE048327T2
(hu )
2020-07-28
PD-1/PD-L1 és CD80(B7-1)/PD-L1 protein/protein interakciók makrociklikus inhibitorai
IL269466A
(en )
2019-11-28
Pd-1/pd-l1 inhibitors
EP3230319B8
(en )
2022-10-12
Anti-pd-1 antibodies and methods of use thereof
EP3168236A4
(en )
2018-01-10
Anti-canine pd-1 antibody or anti-canine pd-l1 antibody
IL251276A0
(en )
2017-05-29
Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
DK3149042T3
(da )
2019-11-04
PD-L1-antistoffer og anvendelser deraf
EP3200787A4
(en )
2018-03-28
Inhibitors of irak4 activity
EP3200788A4
(en )
2018-02-28
Inhibitors of irak4 activity
EP3200789A4
(en )
2018-04-11
Inhibitors of irak4 activity
PL3179992T3
(pl )
2022-08-16
Kombinacje terapeutyczne inhibitora BTK, inhibitora PD-1 i/lub inhibitora PD-L1
EP3200790A4
(en )
2018-05-16
Inhibitors of irak4 activity
PL3177329T3
(pl )
2020-09-21
Układ do natychmiastowego uwalniania substancji aktywnych
EP3201339A4
(en )
2018-09-19
Targeted augmentation of nuclear gene output
EP3198800A4
(en )
2018-06-20
Behavioral detection of malware agents
EP3222717A4
(en )
2018-04-25
Method of amplifying circular dna
EP3105327A4
(en )
2017-10-18
Compositions and methods of using microrna inhibitors
EP3191593A4
(en )
2018-01-24
Microrna inhibitor system and methods of use thereof
EP3123439A4
(en )
2017-09-06
Method of providing activity notification and device thereof
EP3142659A4
(en )
2017-09-27
Hiv-1 protease inhibitors and uses thereof
IL252191A0
(en )
2017-07-31
Compositions and methods for modulating at2r activity
EP3223613A4
(en )
2018-07-18
4-fluoro-thio-containing inhibitors of app2, compositions thereof and method of use
TH1501005532A
(th )
2017-10-27
สารยับยั้งชนิดมาโครไซคลิกของการทำอันตรกิริยาของโปรตีน/โปรตีนของ pd-1/pd-l1 และ cd80(b7-1)/pd-l1
HK1237270A1
(en )
2018-04-13
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions